Cost savings with intramuscular anticholinergics.
Markowitz
J S
JS
McLeod-Bryant
S
S
Jackson
C W
CW
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D001590:Benztropine / Q000191:economics; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000191:economics* / Q000627:therapeutic use; D017046:Cost Savings; D004155:Diphenhydramine / Q000008:administration & dosage* / Q000191:economics*; D016527:Drug Costs; D016568:Drugs, Generic / Q000008:administration & dosage / Q000191:economics; D017721:Hospital Costs / Q000706:statistics & numerical data; D006801:Humans; D007273:Injections, Intramuscular / Q000191:economics; D001523:Mental Disorders / Q000188:drug therapy; D010607:Pharmacy Service, Hospital / Q000191:economics
D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D016568:Drugs, Generic; D001590:Benztropine; D004155:Diphenhydramine